Comparison of speech and language therapy techniques for speech problems in Parkinson's disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2012, Pages

  Herd, Clare P ^a   Tomlinson, Claire L ^a   Deane, Katherine H O ^b   Brady, Marian C ^c   Smith, Christina H ^d   Sackley, Catherine M ^e   Clarke, Carl E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREATHING EXERCISE; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; DIAGNOSTIC TEST; HUMAN; INTERMETHOD COMPARISON; LEE SILVERMANVOICE TREATMENT ARTIC; LEE SILVERMANVOICE TREATMENT LOUD; LOUDNESS; META ANALYSIS; NOISE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; REVIEW; SPEECH ANALYSIS; SPEECH AND LANGUAGE REHABILITATION; SPEECH DISORDER; SPEECH TEST; SYSTEMATIC REVIEW; DYSARTHRIA; EPIDEMIOLOGY; METHODOLOGY; SPEECH INTELLIGIBILITY; SPEECH THERAPY;

BIAS (EPIDEMIOLOGY); DYSARTHRIA; HUMANS; LANGUAGE THERAPY; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPEECH INTELLIGIBILITY; SPEECH THERAPY;

EID: 84866773013     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002814.pub2     Document Type: Review

References (50)

1. Constantinescu G, Theodoros D, Russell T, Ward E, Wilson S, Wootton R. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial. International Journal of Language & Communication Disorders 2011;46(1):1-16.
2. Halpern A, Spielman J, Ramig L, Cable J, Panzer I, Sharpley A. The effects of loudness and noise on speech intelligibility in Parkinson's disease. Movement Disorders 2007;22(16):S105.
3. Healy V. A comparison of the efficacy of two methods of rate control in the speech of people with Parkinson's disease. Internal report, Manchester Royal Infirmary 2002.
4. Lowit A, Dobinson C, Timmins C, Howell P, Kroger B. The effectiveness of traditional methods and altered auditory feedback in improving speech rate and intelligibility in speakers with Parkinson's disease. International Journal of Speech-Language Pathology 2010;12(5):426-36.
5. Baumgartner CA, Sapir A, Ramig LO. Perceptual voice quality changes following phonatory-respiratory effort treatment (LSVT) vs. respiratory effort treatment for individuals with Parkinson's disease. Submitted to Journal of Voice.
6. Ramig LO, Countryman S. O'Brien C, Hoehn M, Thompson L. Intensive speech treatment for patients with Parkinson's disease: Short- and long-term comparison of two techniques. Neurology 1996;47:1496-1504.
7. Ramig LO, Dromey C. Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson's disease. Journal of Speech and Hearing Research 1996;39:798-807.
8. Ramig LO, Hoyt P, Seeley E, Sapir S. Voice treatment (LSVT) for IPD: Perceptual findings. Parkinsonism and related disorders 1999;5(Supplement):S42.
9. Ramig LO, Sapir S, Countryman S, Pawlas AA, O'Brien C, Hoehn M, et al. Intensive voice treatment (LSVT (R)) for patients with Parkinson's disease: a 2 year follow up. Journal of Neurology Neurosurgery and Psychiatry 2001;71(4):493-8.
10. Ramig LOS, Countryman S, Thompson LL, Hori Y. Comparison of two forms of intensive speech treatment for Parkinson's disease. Journal of Speech and Hearing Research 1995;38:1232-51.
11. Sapir S, Ramig LO, Hoyt P, Countryman S, O'Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT (R)) for Parkinson's disease: A comparison with an alternative speech treatment. Folia Phoniatrica et Logopaedica 2002;54(6):296-303.
12. Smith ME, Ramig LO, Dromey C, Perez KS, Samandari R. Intensive voice treatment in Parkinson's disease: Laryngostroboscopic findings. Journal of Voice 1995;9(4):453-9.
13. Scott S, Caird FI. Speech therapy for Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1983;46:140-4.
14. Scott S, Caird FI, Williams BO. The effect of speech therapy on communication. In: S. Scott, F.I. Caird, B.O. Williams editor(s). Communication in Parkinson's disease. Beckenham, Kent: Croom Helm Ltd, 1985:47-60.
15. Adams SG, Page AD, Jog M. Summary feedback schedules and speech motor learning in Parkinson's disease. Journal of Medical Speech-Language Pathology 2002;10(4):215-20.
16. de Swart BJM, Willemse SC, Maassen BAM, Horstink MWIM. Improvement of voicing in patients with Parkinson's disease by speech therapy. Neurology 2003;60(3):498-500.
17. Pacchetti C, Mancini F, Aglieri R, Fundaro C, Martignoni E, Nappi G. Active music therapy in Parkinson's disease: An integrative method for motor and emotional rehabilitation. Psychosomatic Medicine 2000;62(3):386-93.
18. Tindall LR, Huebner RA. The impact of an application of telerehabilitation technology on caregiver burden. International Journal of Telerehabilitation 2009;1(1):3-7.
19. Beck AT, Ward CH, Mendelsohn M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961;4(6):561-71.
20. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care 1981;19(8):787-805.
21. Biary, N, P.A. Pimental, P.W. Langenberg. A double-blind trial of clonazepam in the treatment of parkinsonian dysarthria. Neurology 1988;38:255-258.
22. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Journal of the American Medical Association 1996;276(8):637-9.
23. Dann N. Saunders H, Hunter PC, Hughes AJ. The response of parkinsonian dysarthria to dopaminergic stimulation. Movement Disorders 1994;9(Supplement 1):83.
24. Darley, Aronson, Brown. Motor Speech Disorders. Philadelphia: Saunders, 1969.
25. Fleiss JL. The statistical basis of meta-analysis. Statistical Methods in Medical Research 1993;2(2):121-45.
26. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1988;51:745-52.
27. Golding E. The Middlesex Elderly Assessment of Mental State (MEAMS). Suffolk, UK: Thames ValleyTest Company. Suffolk, England: Thames Valley Test Company, 1989.
28. The Global Parkinson's Disease Survey. An insight into quality of life with Parkinson's disease. The Parkinson's Disease Society of the United Kingdom 2000.
29. Halliday MAK. A course in spoken English: Intonation. London: Oxford University Press, 1970.
30. Herd C, Tomlinson CL, Deane KH O, Brady MC, Smith C, Sackley C, Clarke CE. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Cochrane Database of Systematic Reviews In Press.
31. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration 2011, 2011.
32. Karlsen KH, Larsen JP, Tandeburg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1999;66(4):431-5.
33. Lloyd M. The new community care for people for people with Parkinson's disease and their carers. In: Percival R, P. Hobson editor(s). Parkinson's Disease. Studies in Psycological and Social Care. London: BPS Books, 1999:13-59.
34. Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and cooccurance of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. Journal of Speech and Hearing Disorders 1978;43:47-57. [MEDLINE: 78134090]
35. Mawdsley C, Gamsu CV. Periodicity of speech in Parkinson's disease. Nature 1971;231(5301):315-6. [MEDLINE: 71202389]
36. Miller N, Noble E, Jones D, Deane KHO, Gibb C. Survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: patients' and carers' perspectives. International Journal of Language & Communication Disorders 2011;46(2):179-88.
37. Miller N, Deane KHO, Jones D, Noble E, Gibb C. National survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: therapists' practices. International Journal of Language & Communication Disorders 2011;46(2):189-201.
38. The national collaborating centre for chronic conditions. Parkinson's disease: National clinical guideline for diagnosis and management in primary and secondary care. Royal College of Physicians, London. London: Royal College of Physicians, 2006.
39. O'Reilly F, Finnan F, Allwright S, Davey Smith G, Ben-Shlomo Y. The effects of caring for a spouse with Parkinson's disease on social, psychological and physical well-being. British Journal of General Practice 1996;46:507-12.
40. Parkinson's disease society. Life with Parkinson's today -room for improvement. Parkinson's disease society, London 2008.
41. Ramig LO, Pawlas A, Countryman S. The Lee Silverman Voice Treatment (LSVT): A practical guide to treating the voice and speech disorders in Parkinson's disease. Iowa City: University of Iowa, 1995.
42. Rosenbek, LaPointe. The dysarthrias: Description, diagnosis and treatment. In: Johns DF editor(s). Clinical management of neurogenic communicative disorders. 2nd Edition. Boston: Little Brown and Co, 1985.
43. Sapir S, Pawlas AA, Ramig LO, Countryman S, O'Brien C, Hoehn MM, et al. Voice and speech abnormalities in Parkinson disease: Relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. Journal of Medical Speech-Language Pathology 2001;9(4):213-26.
44. Stewart C, Winfield L, Hunt A, Bressman SB, Fahn S, Blitzer A, et al. Speech dysfunction in early Parkinson's disease. Movement Disorders 1995;10(5):562-5. [MEDLINE: 96064327]
45. Streifler M, Hofman S. Disorders of verbal expression in Parkinsonism. Advances in Neurology 1984;40:385-93. [MEDLINE: 84124643]
46. Tanner CMJ, Hubble P, Chan P. Epidemiology and genetics of Parkinson's disease. In: Watts R. L, W. C. Koller editor(s). Movement Disorders. Neurologic Principles and Practise. New York: McGraw Hill, 1996:137-60. [ISBN: 0-07-035203-8]
47. Visser M, Van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, Van Hilten JJ. A comprehensive model of health-related quality of life in Parkinson's disease. Journal of Neurology 2008;255(10):1580-7.
48. Yorkston KM, Beukelman DR. Assessment of Intelligibility of Dysarthric Speech. Austin, TX: PRO-ED, 1981.
49. Zach M, Friedman A, Slawek J, Derejko M. Quality of life in polish patients with long-lasting Parkinson's disease. Movement Disorders 2004;19(6):667-72.
50. Deane K, Whurr R, Playford ED, Ben-Shlomo Y, Clarke CE. Speech and language therapy for dysarthria in Parkinson's disease: a comparison of techniques. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD002814]